Condition
Area Under Curve
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 1 (1)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06095895Completed
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
NCT05114551Unknown
ICU Predictive Score of WEaning Success in Patients At Risk of Extubation Failure
NCT04756895Not ApplicableCompleted
Vancomycin Dose Adjustments Comparing Trough Levels to The AUC/MIC Method Using a Bayesian Approach in a Hospitalized Adult Population
NCT03857230Phase 1CompletedPrimary
The Safety and Pharmacokinetics of Primapur and Gonal-f
NCT02292420Completed
The Normal Reference Values of Pulse Oximetry Plethymographic Waveform Parameters
Showing all 5 trials